Skip to main content

Ingrid Galán Cartaña

Institutions of which they are part

Senior researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Ingrid Galán Cartaña

Ingrid Galán Cartaña

Ingrid Galán Cartaña

Institutions of which they are part

Senior researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Papel de los factores hormonales relacionados con la mujer en el riesgo y pronóstico de la E.M.

IP: Mar Tintore Subirana
Collaborators: Susana Otero Romero, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Cristina Auger Acosta, Georgina Arrambide García, Alex Rovira Cañellas, Joaquin Castillo Justribo, Milagros Fraga Pereira
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI15/00170
Duration: 01/01/2016 - 31/12/2019

Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC)

IP: Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC)
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Margarida Capell Maymo, Carmen Tur Gomez, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Silvia Casacuberta Serra, Sergio Vergara Ruiz, Luciana Midaglia Fernandez, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Mireia Castillo Juarez, Nicolás Miguel Fissolo , Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50000
Reference: 2014 SGR 1082
Duration: 01/01/2014 - 31/12/2016

Búsqueda de variantes genéticas causales y estudio de sus implicaciones funcionales en pacientes con esclerosis múltiple

IP: Manuel Comabella Lopez
Collaborators: Jordi Rio Izquierdo, Ingrid Galán Cartaña, Montserrat Moreno Sánchez
Funding agency: Instituto de Salud Carlos III
Funding: 147015
Reference: PI12/02229
Duration: 01/01/2013 - 30/06/2017

El antagonismo de la señalización de las "bone morphogenic proteins" (BMP) como diana para potenciar la neuroregeneración en la esclerosis múltiple

IP: Carmen Espejo Ruiz
Collaborators: Ingrid Galán Cartaña, Carmen Tur Gomez, Herena Eixarch Ahufinger, Elena Antima Martinez Saez, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 103455
Reference: PI12/02144
Duration: 01/01/2013 - 30/06/2017

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Andrea Lorite Gonzalez

Andrea Lorite Gonzalez

Research technician
Cardiovascular Diseases
Read more
Neus Mongay Ochoa

Neus Mongay Ochoa

Postdoctoral researcher
Neuroradiology
Read more
Elba Agusti Rovira

Elba Agusti Rovira

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Laura Martin Fernandez

Laura Martin Fernandez

Postdoctoral researcher
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.